Novel Approaches Against Emerging Antimicrobial Resistance
joint with The Human Microbiome: Ecology and Evolution
Scientific Organizers: Man-Wah Tan and Deborah T. Hung
Date: February 13 - 16, 2022
Location: Fairmont Banff Springs, Banff, AB, Canada
For Updated Health and Safety Guidelines for Keystone Symposia in-person meetings, click here
It has become clear that infectious diseases are among the greatest threats to human health and global stability. Chief among these threats is the rise in antibiotic resistance, which endangers our ability to treat otherwise curable infection. The capacity to discover and develop novel agents to fill the pipeline as existing antibiotics are lost to increasing resistance has to date been limited. The goal of this Keystone Symposia conference is to present cutting-edge approaches to antibiotic discovery, including application of expanded chemical space, systems chemical biology, and artificial intelligence; and novel strategies for treating resistant infection, including CRISPR, vaccines, antibodies, phages and conjugates. The promise, challenges, and development paths of these new approaches and strategies will be discussed in the context of lessons learned from prior antibiotic development programs, and new innovations in clinical and regulatory pathways. Additionally, this conference will be held jointly with “The Human Microbiome: Ecology and Evolution.” This pairing will help to facilitate exploration of the impact of antibiotics on the microbiome and the microbiome on antibiotic resistance.
Scholarship Deadline: October 28 2021 details
Keystone Symposia is committed to maintaining a positive and respectful environment at its meetings. To this end, please review and comply with our policies
Registered attendees of one meeting in a joint pair may participate in sessions of the other, pending space availability.